pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-6768 |
Genomic Coordinates | chr16: 2463967 - 2464038 |
Description | Homo sapiens miR-6768 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | ||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-6768-3p | |||||||||||||||||||||||||||||||||||||||||||||
Sequence | 45| CAAAGGCCACAUUCUCCUGUGCAC |68 | |||||||||||||||||||||||||||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||||||||||||||||||||||||||
Experiments | Meta-analysis | DRVs in miRNA |
|
|||||||||||||||||||||||||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||||||||||||||||||||||||||
Putative Targets |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | ADIPOR2 | ||||||||||||||||||||
Synonyms | ACDCR2, PAQR2 | ||||||||||||||||||||
Description | adiponectin receptor 2 | ||||||||||||||||||||
Transcript | NM_024551 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on ADIPOR2 | |||||||||||||||||||||
3'UTR of ADIPOR2 (miRNA target sites are highlighted) |
>ADIPOR2|NM_024551|3'UTR 1 TACCTACCAGTCTCCAGGGACTATGACCCTAAACCAGGGCCTGCGGCACTTGCGGGCCTCCCTGCTGGCTACTGATGCCA 81 GTACCAGAGGAGCCCCAAAACTTTGACAGCCTCGTGGGCTTTGTGACGGCCCAGGGGCTCTGCGTGGTACATGACTGAGA 161 AGAGAAAAACAAAAATAAATCATACCTCAAAGGATGGAGTGCATCAATTGGGAGAAAAGGAGACATAGCCCAAACCCTGG 241 CTTATTCTTGGGATCTACTGATTGCGGGCTCTGCAAGACCCTTGGCAAACTGGCTTCTGATCCATATCATATTTATTTGT 321 AGAAGATGGCGAAACAGTTTAGCTGGTGGTTCTTTCTTCTCCCTTTCTCTCTCTCTATGACAATAATACAAACCAATTTA 401 AGTGAACATTTATATCCGATAAGGGGTGGGAGTGTGATTTTAAATGCTCTTTTGGGAGAACAAAGAAATTAATGTAAATA 481 AGATTTCTAACTGTTTAAATAAGACTTTATATAAATGTTTAAAACATAGGGGTAAGGGAGGGAGGGAGAATTTTTGTATA 561 GAATGAAACATGCAAGTACCACACACTGTTTGAATTTTGCACAAAAAGTGACTGTAGGATCAGGTGATAGCCCCGGAATG 641 TACAGTGTCTTGGTGCACCAAGATGCCTTCTAAAGGCTGACATACCTTGGACCCTAATGGGGCAGAGAGTATAGCCCTAG 721 CCCAGTGGTGACATGACCACTCCCTTTGGGAGGCCTGAGGTAGAGGGGAGTGGTATGTGTTTTCTCAGTGGAAGCAGCAC 801 ATGAGTGGGTGACAGGATGTTAGATAAAGGCTCTAGTTAGGGTGTCATTGTCATTTGAGAGACTGACACACTCCTAGCAG 881 CTGGTAAAGGGGTGCTGGAGGCCATGGAGGAGCTCTAGAAACATTAGCATGGGCTGATCTGATTACTTCCTGGCATCCCG 961 CTCACTTTTATGGGAAGTCTTATTAGAGGGATGGGACAGTTTTCCATATCCTTGCTGTGGAGCTCTGGAACACTCTCTAA 1041 ATTTCCCTCTATTAAAAATCACTGCCCTAACTACACTTCCTCCTTGAGGGAATAGAAATGGACCTTTCTCTGACATAGTT 1121 CTTGGCATGGGAGCCAGCCACAAATGAGATTCTGACGTGTCCAGGTTTCTCCTGAGCTCATCTACATAGATTGGTAGACC 1201 CTTCCTTTGGATTAGGAAAGATGAGTTTTACCTCTGGTACACTGTCTTGGTAAGCCTGGATGTGACAGACACCTCGGCTC 1281 TCCTTGAATAAGAAAGCCAGCAGAACTCTTAAAGCCAGTTGTAGTACGGAGTTGTCAGCACTCACTGAACCTCACTTTAC 1361 AGGGATAAGAGTGGTGTGGCATTTTAAATACAATGGTATGTTATTGCCAGGGAGTGAGGTACAAGACGATGGCTCATGTC 1441 ACAGGCCTACCTGATACGGTGTCAGAGAAAGTGGTGGGGAAAGGATCTGGTTCATGGAATTCTGATCTTGGCCCATAGGT 1521 GAACCACCAAAATAGTGCTCGAGTCTTAGGTTACTGTCATCAAAGACTTGGGATGACTCCATTATATCCTGGGGTTGTGG 1601 GTATTAGAACTAAATATGGAGGTCCTGAGCATGGGGACTGGCGTCCTCAGTAGGTGTTTGGGAATATGGGAAGGGTCTCC 1681 TATTTATTCAATAGAGTTTTCTCAGTTATTTTCCTCCCTTGCCCTTGCAATCTCCAGCAAAAGGTGGGATCTAGGAAGAA 1761 AGAATCCAGTGTAGAAGTTGAGAAGAACTTGAACGTTTTGGTTCTGGATAAGGTCACTGTCCTAGGTGCTAGGTGGACCG 1841 AGCAAAAGACTCAGTGGATGAACTGGTGCAGTGCCTGACAGAATAAAGAACAGTATTAATCCCTTTGAGAAAGCATAGTC 1921 CAGCAGGACAGTGGCCATTTGGACAGAAGCCCACTTAGTTTCTTGGGAGCAACAGCACGTATCAGAAGCCAGACTTGCTC 2001 TTCGGTCATGCACTTTGGGATACAGCGTATAGGTGCAGCCCTGTCACAACACCAACAGAAGTAGCAGCCTCTGGGTGCAG 2081 TCACCCACACCCCAAAGCTGGAAGGATCTGGTTCAACATAGCACAAACCCTTAGGAAAAATGAAATTAACATCACTGATG 2161 TGTAATCCAGTAAAATCTCCCTTTTTCGGGTGTGTATGTGGGCATGTGCCCATTTCTATGTGTGTGTCTACGTGCAGCTC 2241 ACTACCAACAGCCTCATGTGCACTTGACCTGACAGTGCTCGCTGAGAACTCTCACCAGGTTGGCGCCTGAATGCCTTACT 2321 CTCAGCAGTCAGAGGCTTGCTTGCTCTGTGCAGATTTTTAATTTTCTTTTTTGGCCCTAGGCTGGTTGGGACCTCTACAG 2401 CTTCATTCTTTCACCATTAAATAGTGGCCTTTTTCAGTATTTTCCCTCTTCCCCTTTATAAATTATGCTAAAGCCACAAA 2481 GCACATTTTTGGGGATCATAGAAGGTTGGGGTTCCAGAAAGGCATCTGTGTGATGGTTCCATTGATGTGGGATTTCCCTA 2561 CTTGCTGTATTCTCAGTTTCTAATAAAAAGAACCAAATGAAATATGAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545216. RNA binding protein: AGO2. Condition:miR-124 transfection
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
CLIP-seq Support 1 for dataset GSM545216 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / miR-124 transfection |
Location of target site | ENST00000357103.4 | 3UTR | CUUCAUUCUUUCACCAUUAAAUAGUGGCCUUU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
95 hsa-miR-6768-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT060980 | LAMC1 | laminin subunit gamma 1 | 2 | 2 | ||||||||
MIRT145633 | LASP1 | LIM and SH3 protein 1 | 2 | 2 | ||||||||
MIRT161065 | CDV3 | CDV3 homolog | 2 | 2 | ||||||||
MIRT161171 | SLC25A36 | solute carrier family 25 member 36 | 2 | 2 | ||||||||
MIRT177407 | ZMYND11 | zinc finger MYND-type containing 11 | 2 | 2 | ||||||||
MIRT262237 | WAC | WW domain containing adaptor with coiled-coil | 2 | 2 | ||||||||
MIRT300236 | INO80D | INO80 complex subunit D | 2 | 2 | ||||||||
MIRT373993 | PEBP1 | phosphatidylethanolamine binding protein 1 | 2 | 4 | ||||||||
MIRT379949 | CRY2 | cryptochrome circadian clock 2 | 2 | 2 | ||||||||
MIRT405244 | ADIPOR2 | adiponectin receptor 2 | 2 | 2 | ||||||||
MIRT441622 | ROCK1 | Rho associated coiled-coil containing protein kinase 1 | 2 | 6 | ||||||||
MIRT441807 | NOC3L | NOC3 like DNA replication regulator | 2 | 2 | ||||||||
MIRT442007 | NDUFV3 | NADH:ubiquinone oxidoreductase subunit V3 | 2 | 2 | ||||||||
MIRT442254 | DCTN5 | dynactin subunit 5 | 2 | 2 | ||||||||
MIRT442413 | LIMD1 | LIM domains containing 1 | 2 | 2 | ||||||||
MIRT442741 | SERINC5 | serine incorporator 5 | 2 | 2 | ||||||||
MIRT442796 | CEP170 | centrosomal protein 170 | 2 | 2 | ||||||||
MIRT443332 | OCRL | OCRL, inositol polyphosphate-5-phosphatase | 2 | 2 | ||||||||
MIRT443602 | ZNF91 | zinc finger protein 91 | 2 | 2 | ||||||||
MIRT443695 | KCNN3 | potassium calcium-activated channel subfamily N member 3 | 2 | 2 | ||||||||
MIRT443749 | ELL2 | elongation factor for RNA polymerase II 2 | 2 | 2 | ||||||||
MIRT446376 | THSD4 | thrombospondin type 1 domain containing 4 | 2 | 2 | ||||||||
MIRT452491 | BANK1 | B-cell scaffold protein with ankyrin repeats 1 | 2 | 16 | ||||||||
MIRT456028 | PSMA7 | proteasome subunit alpha 7 | 2 | 2 | ||||||||
MIRT461191 | TRIP4 | thyroid hormone receptor interactor 4 | 2 | 16 | ||||||||
MIRT464498 | UCK2 | uridine-cytidine kinase 2 | 2 | 2 | ||||||||
MIRT466640 | TAOK1 | TAO kinase 1 | 2 | 16 | ||||||||
MIRT466703 | TAF13 | TATA-box binding protein associated factor 13 | 2 | 4 | ||||||||
MIRT467765 | SLC30A7 | solute carrier family 30 member 7 | 2 | 2 | ||||||||
MIRT469973 | PTPRF | protein tyrosine phosphatase, receptor type F | 2 | 2 | ||||||||
MIRT470539 | COASY | Coenzyme A synthase | 2 | 2 | ||||||||
MIRT474827 | KIAA0226 | RUN and cysteine rich domain containing beclin 1 interacting protein | 2 | 2 | ||||||||
MIRT475961 | GXYLT1 | glucoside xylosyltransferase 1 | 2 | 4 | ||||||||
MIRT476459 | GBA2 | glucosylceramidase beta 2 | 2 | 2 | ||||||||
MIRT477658 | EFNA1 | ephrin A1 | 2 | 2 | ||||||||
MIRT485320 | MZT1 | mitotic spindle organizing protein 1 | 2 | 4 | ||||||||
MIRT485656 | CYP1B1 | cytochrome P450 family 1 subfamily B member 1 | 2 | 2 | ||||||||
MIRT494145 | CTC1 | CST telomere replication complex component 1 | 2 | 10 | ||||||||
MIRT495127 | CXorf67 | chromosome X open reading frame 67 | 2 | 2 | ||||||||
MIRT498279 | POFUT1 | protein O-fucosyltransferase 1 | 2 | 2 | ||||||||
MIRT498432 | DDX39A | DExD-box helicase 39A | 2 | 2 | ||||||||
MIRT498853 | LITAF | lipopolysaccharide induced TNF factor | 2 | 4 | ||||||||
MIRT499661 | SDR42E1 | short chain dehydrogenase/reductase family 42E, member 1 | 2 | 2 | ||||||||
MIRT502927 | CDC42SE1 | CDC42 small effector 1 | 2 | 4 | ||||||||
MIRT503758 | CEP19 | centrosomal protein 19 | 2 | 6 | ||||||||
MIRT507753 | CERS2 | ceramide synthase 2 | 2 | 4 | ||||||||
MIRT507893 | CAMSAP2 | calmodulin regulated spectrin associated protein family member 2 | 2 | 4 | ||||||||
MIRT510091 | PPWD1 | peptidylprolyl isomerase domain and WD repeat containing 1 | 2 | 8 | ||||||||
MIRT527065 | PPP6R1 | protein phosphatase 6 regulatory subunit 1 | 2 | 2 | ||||||||
MIRT530314 | TNFRSF10D | TNF receptor superfamily member 10d | 2 | 2 | ||||||||
MIRT530702 | P2RY1 | purinergic receptor P2Y1 | 2 | 2 | ||||||||
MIRT532378 | LINC00598 | long intergenic non-protein coding RNA 598 | 2 | 2 | ||||||||
MIRT532969 | ZNF148 | zinc finger protein 148 | 2 | 2 | ||||||||
MIRT533958 | TAF1D | TATA-box binding protein associated factor, RNA polymerase I subunit D | 2 | 2 | ||||||||
MIRT535186 | PLEKHA8 | pleckstrin homology domain containing A8 | 2 | 2 | ||||||||
MIRT538751 | CADM1 | cell adhesion molecule 1 | 2 | 2 | ||||||||
MIRT539473 | ADARB2 | adenosine deaminase, RNA specific B2 (inactive) | 2 | 2 | ||||||||
MIRT543858 | APIP | APAF1 interacting protein | 2 | 2 | ||||||||
MIRT558802 | CDON | cell adhesion associated, oncogene regulated | 2 | 2 | ||||||||
MIRT560208 | AK4 | adenylate kinase 4 | 2 | 2 | ||||||||
MIRT560318 | EFHD2 | EF-hand domain family member D2 | 2 | 2 | ||||||||
MIRT560439 | GOLGA7B | golgin A7 family member B | 2 | 2 | ||||||||
MIRT560846 | SUV39H2 | suppressor of variegation 3-9 homolog 2 | 2 | 2 | ||||||||
MIRT562787 | LIMA1 | LIM domain and actin binding 1 | 2 | 2 | ||||||||
MIRT563476 | POLE3 | DNA polymerase epsilon 3, accessory subunit | 2 | 2 | ||||||||
MIRT563829 | RIPK4 | receptor interacting serine/threonine kinase 4 | 2 | 2 | ||||||||
MIRT563996 | SLFN11 | schlafen family member 11 | 2 | 2 | ||||||||
MIRT564596 | ZNF791 | zinc finger protein 791 | 2 | 2 | ||||||||
MIRT565442 | SURF4 | surfeit 4 | 2 | 2 | ||||||||
MIRT566020 | RHOA | ras homolog family member A | 2 | 2 | ||||||||
MIRT566185 | PTPN14 | protein tyrosine phosphatase, non-receptor type 14 | 2 | 2 | ||||||||
MIRT567643 | FAM160A1 | family with sequence similarity 160 member A1 | 2 | 2 | ||||||||
MIRT568484 | ARL5B | ADP ribosylation factor like GTPase 5B | 2 | 2 | ||||||||
MIRT568553 | AKT2 | AKT serine/threonine kinase 2 | 2 | 2 | ||||||||
MIRT613420 | XRCC3 | X-ray repair cross complementing 3 | 2 | 2 | ||||||||
MIRT613638 | ARHGAP35 | Rho GTPase activating protein 35 | 2 | 2 | ||||||||
MIRT614841 | POU2F2 | POU class 2 homeobox 2 | 2 | 2 | ||||||||
MIRT630143 | ZFYVE9 | zinc finger FYVE-type containing 9 | 2 | 2 | ||||||||
MIRT634123 | ZMYM1 | zinc finger MYM-type containing 1 | 2 | 4 | ||||||||
MIRT641841 | TCF7L2 | transcription factor 7 like 2 | 2 | 2 | ||||||||
MIRT647123 | ZNF446 | zinc finger protein 446 | 2 | 2 | ||||||||
MIRT647968 | FBXO31 | F-box protein 31 | 2 | 2 | ||||||||
MIRT658186 | FBXO9 | F-box protein 9 | 2 | 2 | ||||||||
MIRT659097 | DENR | density regulated re-initiation and release factor | 2 | 2 | ||||||||
MIRT668980 | CLCN3 | chloride voltage-gated channel 3 | 2 | 2 | ||||||||
MIRT670351 | C1orf106 | chromosome 1 open reading frame 106 | 2 | 4 | ||||||||
MIRT671826 | TRPM6 | transient receptor potential cation channel subfamily M member 6 | 2 | 2 | ||||||||
MIRT695610 | GATAD1 | GATA zinc finger domain containing 1 | 2 | 2 | ||||||||
MIRT697722 | USP8 | ubiquitin specific peptidase 8 | 2 | 2 | ||||||||
MIRT700069 | RPL14 | ribosomal protein L14 | 2 | 2 | ||||||||
MIRT708474 | MAPKAPK5 | mitogen-activated protein kinase-activated protein kinase 5 | 2 | 2 | ||||||||
MIRT717001 | ARL6IP4 | ADP ribosylation factor like GTPase 6 interacting protein 4 | 2 | 2 | ||||||||
MIRT719591 | TFCP2L1 | transcription factor CP2 like 1 | 2 | 2 | ||||||||
MIRT722026 | CBY3 | chibby family member 3 | 2 | 2 | ||||||||
MIRT722901 | LRRC20 | leucine rich repeat containing 20 | 2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|